Financial PerformanceDespite efforts, the company will not be cash flow positive until 2027, indicating ongoing financial challenges.
Medicare Advantage MembershipThe company anticipates a ~4% decline in Medicare Advantage membership as it exits two unprofitable physician partnerships.
Revenue DeclineIn 2025, the company expects a 2% decline in total revenue as MA enrollment declines and underperforming contracts are left.